-
1
-
-
6044240886
-
Central precocious puberty: Current treatment options
-
Antoniazzi F, Zamboni G. Central precocious puberty: current treatment options. Pediatr Drugs 2004; 6: 211-31
-
(2004)
Pediatr Drugs
, vol.6
, pp. 211-231
-
-
Antoniazzi, F.1
Zamboni, G.2
-
2
-
-
0032761556
-
Central precocious puberty: An overview of diagnosis, treatment, and outcome
-
Lee PA. Central precocious puberty: an overview of diagnosis, treatment, and outcome. Endocrinol Metab Clin North Am 1999; 28: 901-18
-
(1999)
Endocrinol Metab Clin North Am
, vol.28
, pp. 901-918
-
-
Lee, P.A.1
-
3
-
-
0036104055
-
GnRH antagonist in assisted reproduction: A Cochrane review
-
Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002; 17 (4): 874-85
-
(2002)
Hum Reprod
, vol.17
, Issue.4
, pp. 874-885
-
-
Al-Inany, H.1
Aboulghar, M.2
-
4
-
-
13544267642
-
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization
-
Basmati LI, Chantilis SJ, Hurst BS, et al. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005; 83: 321-30
-
(2005)
Fertil Steril
, vol.83
, pp. 321-330
-
-
Basmati, L.I.1
Chantilis, S.J.2
Hurst, B.S.3
-
5
-
-
18844450990
-
Inhibition of human type I gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment
-
Pawson AJ, Maudsley S, Morgan K, et al. Inhibition of human type I gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment. Endocrinology 2005; 146: 2639-49
-
(2005)
Endocrinology
, vol.146
, pp. 2639-2649
-
-
Pawson, A.J.1
Maudsley, S.2
Morgan, K.3
-
6
-
-
33749350141
-
Basal, GnRH-or GnRHa-stimulated LH levels in the diagnosis of central precocious puberty (CPP) in girls: Adequacy of 3rd generation assays
-
[abstract no. 3414.103] Apr 28-May 2; San Francisco (CA)
-
Lee PA, Houk CP, Kunselman AR. Basal, GnRH-or GnRHa-stimulated LH levels in the diagnosis of central precocious puberty (CPP) in girls: adequacy of 3rd generation assays [abstract no. 3414.103]. Pediatric Academic Societies annual meeting; 2006 Apr 28-May 2; San Francisco (CA)
-
(2006)
Pediatric Academic Societies Annual Meeting
-
-
Lee, P.A.1
Houk, C.P.2
Kunselman, A.R.3
-
7
-
-
27844492766
-
The gonadotrophins response to GnRH test is not a predictor of neurological lesion in girls with central precocious puberty
-
Ng SM, Kumar Y, Cody D, et al. The gonadotrophins response to GnRH test is not a predictor of neurological lesion in girls with central precocious puberty. J Pediatr Endocrinol Metab 2005; 18: 849-52
-
(2005)
J Pediatr Endocrinol Metab
, vol.18
, pp. 849-852
-
-
Ng, S.M.1
Kumar, Y.2
Cody, D.3
-
8
-
-
0031023170
-
Adult height in 24 patients treated for growth hormone deficiency and early puberty
-
Adan L, Souberbielle JC, Zucker JM, et al. Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997; 82: 229-33
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 229-233
-
-
Adan, L.1
Souberbielle, J.C.2
Zucker, J.M.3
-
9
-
-
0035705006
-
Psychological evaluation of young women after medical treatment for central precocious puberty
-
Baumann DA, Landolt MA, Wetterwald R, et al. Psychological evaluation of young women after medical treatment for central precocious puberty. Horm Res 2001; 56: 45-50
-
(2001)
Horm Res
, vol.56
, pp. 45-50
-
-
Baumann, D.A.1
Landolt, M.A.2
Wetterwald, R.3
-
10
-
-
33749348865
-
The French Leuprorelin Trial Group, the French Triptorelin Trial Group: Use of 3 month depot GnRH agonist in central precocious puberty
-
[abstract no. A67] Feb 10-13; Salzburg
-
Lahlou N, Blumberg J, Montauban V, et al. The French Leuprorelin Trial Group, the French Triptorelin Trial Group: use of 3 month depot GnRH agonist in central precocious puberty [abstract no. A67]. 8th International Symposium on GnRH analogues; 2005 Feb 10-13; Salzburg
-
(2005)
8th International Symposium on GnRH Analogues
-
-
Lahlou, N.1
Blumberg, J.2
Montauban, V.3
-
11
-
-
33644683854
-
The histrelin implant: A novel treatment for central precocious puberty
-
Hirsch H, Gillis D, Strich D, et al. The histrelin implant: a novel treatment for central precocious puberty. Pediatrics 2005; 116: e798-820
-
(2005)
Pediatrics
, vol.116
-
-
Hirsch, H.1
Gillis, D.2
Strich, D.3
-
12
-
-
0033864024
-
Final height after gonadotropin releasing hormone agonist treatment for central precocious puberty: The Dutch experience
-
Mul D, Oostdijk W, Otten BJ, et al. Final height after gonadotropin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 2000; 13 Suppl. 1: 765-72
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, Issue.1 SUPPL.
, pp. 765-772
-
-
Mul, D.1
Oostdijk, W.2
Otten, B.J.3
-
13
-
-
0034749748
-
Increased final height in precocious puberty after long-term treatment with LHRH agonists: The National Institutes of Health experience
-
Klein KO, Barnes KM, Jones JV, et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001; 86: 4711-6
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 4711-4716
-
-
Klein, K.O.1
Barnes, K.M.2
Jones, J.V.3
-
14
-
-
0033305378
-
Final height after long-term treatment with triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment. French study group of decapeptyl in precocious puberty
-
Carel JC, Roger M, Ispas S, et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of decapeptyl in precocious puberty. J Clin Endocrinol Metab 1999; 84: 1973-8
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 1973-1978
-
-
Carel, J.C.1
Roger, M.2
Ispas, S.3
-
15
-
-
3142714004
-
Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty: Gonadotropin suppressive effect and final height obtained with two different analogs
-
Lanes R, Soros A, Jakubowicz S. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty: gonadotropin suppressive effect and final height obtained with two different analogs. J Pediatr Endocrinol Metab 2004; 17: 759-66
-
(2004)
J Pediatr Endocrinol Metab
, vol.17
, pp. 759-766
-
-
Lanes, R.1
Soros, A.2
Jakubowicz, S.3
-
16
-
-
0036856367
-
Idiopathic precocious puberty versus puberty in adopted children: Auxological response to gonadotropin-releasing hormone agonist treatment and final height
-
Kempers MJ, Otten BJ. Idiopathic precocious puberty versus puberty in adopted children: auxological response to gonadotropin-releasing hormone agonist treatment and final height. Eur J Endocrinol 2002; 147: 609-16
-
(2002)
Eur J Endocrinol
, vol.147
, pp. 609-616
-
-
Kempers, M.J.1
Otten, B.J.2
-
17
-
-
0032807461
-
Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty
-
Arrigo T, Cisternino M, Galluzzi F, et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999; 141: 140-4
-
(1999)
Eur J Endocrinol
, vol.141
, pp. 140-144
-
-
Arrigo, T.1
Cisternino, M.2
Galluzzi, F.3
-
18
-
-
15944371011
-
Treatment of central precocious puberty with gonadotropin-releasing hormone agonist (triptorelin) in girls: Breast development, skeletal maturation, height and weight evolution during and after treatment
-
Messaaoui A, Massa G, Tenoutasse S, et al. Treatment of central precocious puberty with gonadotropin-releasing hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment. Rev Med Brux 2005; 26: 27-32
-
(2005)
Rev Med Brux
, vol.26
, pp. 27-32
-
-
Messaaoui, A.1
Massa, G.2
Tenoutasse, S.3
-
19
-
-
9144263644
-
Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty
-
(Oxf)
-
Paterson WF, McNeill E, Young D, et al. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol (Oxf) 2004; 61: 626-34
-
(2004)
Clin Endocrinol
, vol.61
, pp. 626-634
-
-
Paterson, W.F.1
McNeill, E.2
Young, D.3
-
20
-
-
0033305608
-
Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height. Body proportions, body composition, bone mineral density, and reproductive function
-
Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height. Body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84: 4583-90
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4583-4590
-
-
Heger, S.1
Partsch, C.J.2
Sippell, W.G.3
-
21
-
-
0031978821
-
Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females
-
Bertelloni S, Baroncelli GI, Sorrentino MC, et al. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998; 157: 363-7
-
(1998)
Eur J Pediatr
, vol.157
, pp. 363-367
-
-
Bertelloni, S.1
Baroncelli, G.I.2
Sorrentino, M.C.3
-
22
-
-
0033851232
-
Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotropin-releasing hormone agonists: Italian study group of physiopathology of puberty
-
Rizzo V, DeSanctis V, Corrias A, et al. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotropin-releasing hormone agonists: Italian study group of physiopathology of puberty. J Pediatr Endocrinol Metab 2000; 13 Suppl. 1: 781-6
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, Issue.1 SUPPL.
, pp. 781-786
-
-
Rizzo, V.1
DeSanctis, V.2
Corrias, A.3
-
23
-
-
0035995319
-
Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: Final height results
-
Mul D, Bertelloni S, Carel JC, et al. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res 2002; 58: 1-7
-
(2002)
Horm Res
, vol.58
, pp. 1-7
-
-
Mul, D.1
Bertelloni, S.2
Carel, J.C.3
-
24
-
-
15944393539
-
Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: Evaluation of effectiveness of treatment and recovery of gonadal function. the TAP-144-SR Japanese study group on central precocious puberty
-
Tanaka T, Niimi H, Matsuo N, et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese study group on central precocious puberty. J Clin Endocrinol Metab 2005; 90: 1371-6
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 1371-1376
-
-
Tanaka, T.1
Niimi, H.2
Matsuo, N.3
-
25
-
-
0036004552
-
Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment
-
Couto-Silva J, Adan L, Trivin C, et al. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment. J Pediatr Endocrinol Metab 2002; 15: 297-305
-
(2002)
J Pediatr Endocrinol Metab
, vol.15
, pp. 297-305
-
-
Couto-Silva, J.1
Adan, L.2
Trivin, C.3
-
26
-
-
0027233540
-
Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue
-
Lindner D, Job JC, Chaussain JL. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue. Eur J Pediatr 1993; 152: 393-6
-
(1993)
Eur J Pediatr
, vol.152
, pp. 393-396
-
-
Lindner, D.1
Job, J.C.2
Chaussain, J.L.3
-
27
-
-
0038699006
-
Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: Results of a randomized controlled study
-
Carel J-C, Chatelain P, Rochiccioli P, et al. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab 2003; 88: 1587-93
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1587-1593
-
-
Carel, J.-C.1
Chatelain, P.2
Rochiccioli, P.3
-
28
-
-
0037421981
-
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature
-
Yanovski JA, Rose SR, Municchi G, et al. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 2003; 348: 908-17
-
(2003)
N Engl J Med
, vol.348
, pp. 908-917
-
-
Yanovski, J.A.1
Rose, S.R.2
Municchi, G.3
-
29
-
-
0041912931
-
The effects of manipulation of puberty on growth
-
Lee PA. The effects of manipulation of puberty on growth. Horm Res 2003; 60 Suppl. 1: 60-7
-
(2003)
Horm Res
, vol.60
, Issue.1 SUPPL.
, pp. 60-67
-
-
Lee, P.A.1
-
30
-
-
0032875673
-
Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations
-
Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999; 104: 1010-4
-
(1999)
Pediatrics
, vol.104
, pp. 1010-1014
-
-
Walvoord, E.C.1
Pescovitz, O.H.2
-
31
-
-
0032863920
-
Combined use of growth hormone and gonadotropin-releasing hormone analogues: The National Cooperative Growth Study experience
-
Kohn B, Julius JR, Blethen SL. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the National Cooperative Growth Study experience. Pediatrics 1999; 104: 1014-8
-
(1999)
Pediatrics
, vol.104
, pp. 1014-1018
-
-
Kohn, B.1
Julius, J.R.2
Blethen, S.L.3
-
32
-
-
0033856965
-
Combined therapy with GnRH analog plus growth hormone in central precocious puberty
-
Pucarelli I, Segni M, Ortore M, et al. Combined therapy with GnRH analog plus growth hormone in central precocious puberty. J Pediatr Endocrinol Metab 2000; 13: 811-20
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, pp. 811-820
-
-
Pucarelli, I.1
Segni, M.2
Ortore, M.3
-
33
-
-
0141891455
-
Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: A further contribution
-
Pucarelli I, Segni M, Ortore M, et al. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003; 16: 1005-10
-
(2003)
J Pediatr Endocrinol Metab
, vol.16
, pp. 1005-1010
-
-
Pucarelli, I.1
Segni, M.2
Ortore, M.3
-
34
-
-
7644230926
-
Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty
-
Tuvemo T, Jonsson B, Gustafsson J, et al. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty. Acta Paediatr 2004; 93: 1456-62
-
(2004)
Acta Paediatr
, vol.93
, pp. 1456-1462
-
-
Tuvemo, T.1
Jonsson, B.2
Gustafsson, J.3
-
35
-
-
0035724632
-
Gonadtrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty
-
(Oxf)
-
Mul D, Oostdijk W, Waelkens JJ, et al. Gonadtrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty. Clin Endocrinol (Oxf) 2001; 55: 121-9
-
(2001)
Clin Endocrinol
, vol.55
, pp. 121-129
-
-
Mul, D.1
Oostdijk, W.2
Waelkens, J.J.3
-
36
-
-
0026521530
-
Height prognosis of children with true precocious puberty and growth hormone deficiency: Effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone
-
Cara J, Kreiter M, Rosenfield R. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. J Pediatr 1992; 120: 709-15
-
(1992)
J Pediatr
, vol.120
, pp. 709-715
-
-
Cara, J.1
Kreiter, M.2
Rosenfield, R.3
-
37
-
-
0042413998
-
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency
-
Reiter EO, Lindberg A, Ranke MB, et al. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency. Horm Res 2003; 60: 68-73
-
(2003)
Horm Res
, vol.60
, pp. 68-73
-
-
Reiter, E.O.1
Lindberg, A.2
Ranke, M.B.3
-
38
-
-
0033009734
-
When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue
-
Tanaka T, Satoh M, Yasunaga T, et al. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue. Acta Paediatr Suppl 1999; 88: 85-8
-
(1999)
Acta Paediatr Suppl
, vol.88
, pp. 85-88
-
-
Tanaka, T.1
Satoh, M.2
Yasunaga, T.3
-
39
-
-
4644360087
-
Benefit of postponing normal puberty for improving final height
-
Wit JM, Balen HV, Kamp GA, et al. Benefit of postponing normal puberty for improving final height. Eur J Endocrinol 2004; 151: S41-5
-
(2004)
Eur J Endocrinol
, vol.151
-
-
Wit, J.M.1
Balen, H.V.2
Kamp, G.A.3
-
40
-
-
0034999823
-
The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: Results from a controlled study
-
Saggese G, Federico G, Barsanti S, et al. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study. J Clin Endocrinol Metab 2001; 86: 1900-4
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1900-1904
-
-
Saggese, G.1
Federico, G.2
Barsanti, S.3
-
41
-
-
0034454208
-
Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: Results of a prospective, randomized trial
-
Mericq MV, Eggers M, Avila A, et al. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 2000; 85: 569-73
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 569-573
-
-
Mericq, M.V.1
Eggers, M.2
Avila, A.3
-
42
-
-
0034454578
-
Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone
-
Pasquino AM, Pucarelli I, Roggini M, et al. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J Clin Endocrinol Metab 2000; 85: 619-22
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 619-622
-
-
Pasquino, A.M.1
Pucarelli, I.2
Roggini, M.3
-
43
-
-
0034913704
-
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation
-
Kamp GA, Mul D, Waelkens JJ, et al. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab 2001; 86: 2969-75
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 2969-2975
-
-
Kamp, G.A.1
Mul, D.2
Waelkens, J.J.3
-
44
-
-
0037260568
-
Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls
-
Maniati-Christidi M, Livadas S, Voutetakis A, et al. Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls. Clin Pediatr 2003; 42: 59-65
-
(2003)
Clin Pediatr
, vol.42
, pp. 59-65
-
-
Maniati-Christidi, M.1
Livadas, S.2
Voutetakis, A.3
-
45
-
-
0027213507
-
Congenital adrenal hyperplasia complicated by central precocious puberty: Treatment with LHRH-agonist analogue
-
Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue. Ann N Y Acad Sci 1993; 687: 250-4
-
(1993)
Ann N Y Acad Sci
, vol.687
, pp. 250-254
-
-
Dacou-Voutetakis, C.1
Karidis, N.2
-
46
-
-
0035034620
-
Growth hormone therapy alone or in combination with gonadotropin- releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia
-
Quintos JB, Vogiatzi MG, Harbison MD, et al. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 1511-7
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1511-1517
-
-
Quintos, J.B.1
Vogiatzi, M.G.2
Harbison, M.D.3
-
47
-
-
33749366240
-
Treatment with growth hormone and GnRH analogue improves final height in children with congenital adrenal hyperplasia
-
[abstract no. P2-382] Jun 18-21; Philadelphia (PA)
-
Vogiatzi MG, Lin-Su K, New MI. Treatment with growth hormone and GnRH analogue improves final height in children with congenital adrenal hyperplasia [abstract no. P2-382]. Endocrine Society annual meeting; 2003 Jun 18-21; Philadelphia (PA)
-
(2003)
Endocrine Society Annual Meeting
-
-
Vogiatzi, M.G.1
Lin-Su, K.2
New, M.I.3
-
48
-
-
3142735316
-
Catch-up growth in severe juvenile hypothyroidism: Treatment with a GnRH analog
-
Teng L, Bui H, Bachrach L, et al. Catch-up growth in severe juvenile hypothyroidism: treatment with a GnRH analog. J Pediatr Endocrinol Metab 2004; 17: 345-54
-
(2004)
J Pediatr Endocrinol Metab
, vol.17
, pp. 345-354
-
-
Teng, L.1
Bui, H.2
Bachrach, L.3
-
49
-
-
0034221722
-
LHRH analogue and growth hormone did not improve the final height of a patient with juvenile hypothyroidism accompanied by precocious puberty
-
[letter]
-
Miyazaki R, Yanagawa N, Higashino H, et al. LHRH analogue and growth hormone did not improve the final height of a patient with juvenile hypothyroidism accompanied by precocious puberty [letter]. Arch Dis Child 2000; 83: 89
-
(2000)
Arch Dis Child
, vol.83
, pp. 89
-
-
Miyazaki, R.1
Yanagawa, N.2
Higashino, H.3
-
50
-
-
0033862111
-
Growth in four patients on combined treatment with LHRH analogue and growth hormone after renal transplantation
-
Alonso G, Ferraris J, Pasqualini T. Growth in four patients on combined treatment with LHRH analogue and growth hormone after renal transplantation. J Pediatr Endocrinol Metab 2000; 13: 941-3
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, pp. 941-943
-
-
Alonso, G.1
Ferraris, J.2
Pasqualini, T.3
-
51
-
-
33749346750
-
Combined use of gonadotropin releasing hormone analogue (GnRHa) and growth hormone (GH) in pediatrics
-
[abstract no. A69] Feb 10-13; Salzburg
-
Houk CP, Lee PA. Combined use of gonadotropin releasing hormone analogue (GnRHa) and growth hormone (GH) in pediatrics [abstract no. A69]. 8th International Symposium on GnRH analogues; 2005 Feb 10-13; Salzburg
-
(2005)
8th International Symposium on GnRH Analogues
-
-
Houk, C.P.1
Lee, P.A.2
-
52
-
-
1642349298
-
Germline stem cells and follicular renewal in the postnatal mammalian ovary
-
Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428: 145-50
-
(2004)
Nature
, vol.428
, pp. 145-150
-
-
Johnson, J.1
Canning, J.2
Kaneko, T.3
-
53
-
-
0029843583
-
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy
-
Blumenfeld Z, Avivi I, Linn S, et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620-6
-
(1996)
Hum Reprod
, vol.11
, pp. 1620-1626
-
-
Blumenfeld, Z.1
Avivi, I.2
Linn, S.3
-
54
-
-
0032724844
-
Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women
-
Blumenfeld Z, Avivi I, Ritter M, et al. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Investig 1999; 6: 229-39
-
(1999)
J Soc Gynecol Investig
, vol.6
, pp. 229-239
-
-
Blumenfeld, Z.1
Avivi, I.2
Ritter, M.3
-
55
-
-
0035236187
-
Ovarian rescue/protection from chemotherapeutic agents
-
Blumenfeld Z. Ovarian rescue/protection from chemotherapeutic agents. J Soc Gynecol Investig 2001; 8 (1 Suppl.): S60-4
-
(2001)
J Soc Gynecol Investig
, vol.8
, Issue.1 SUPPL.
-
-
Blumenfeld, Z.1
-
56
-
-
0030769548
-
Prevention of gonadal damage during cytotoxic therapy
-
Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997; 29: 199-206
-
(1997)
Ann Med
, vol.29
, pp. 199-206
-
-
Blumenfeld, Z.1
Haim, N.2
-
57
-
-
0033931644
-
Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosis treated by chemotherapy
-
Blumenfeld Z, Shapiro D, Shteinberg M, et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosis treated by chemotherapy. Lupus 2000; 9: 401-5
-
(2000)
Lupus
, vol.9
, pp. 401-405
-
-
Blumenfeld, Z.1
Shapiro, D.2
Shteinberg, M.3
-
58
-
-
0842285305
-
Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy
-
Mardesic T, Snajderova M, Sramkova L, et al. Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy. Eur J Gynaecol Oncol 2004; 25: 90-2
-
(2004)
Eur J Gynaecol Oncol
, vol.25
, pp. 90-92
-
-
Mardesic, T.1
Snajderova, M.2
Sramkova, L.3
-
59
-
-
20444468503
-
Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a
-
Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 2005; 34: 40-3
-
(2005)
J Natl Cancer Inst Monogr
, vol.34
, pp. 40-43
-
-
Blumenfeld, Z.1
Eckman, A.2
-
60
-
-
0038627514
-
Multi-factorial role of GnRH-I and GnRH-II in the human ovary
-
Apr 28
-
Leung PC, Cheng CK, Zhu XM. Multi-factorial role of GnRH-I and GnRH-II in the human ovary. Mol Cell Endocrinol 2003 Apr 28; 202 (1-2): 145-53
-
(2003)
Mol Cell Endocrinol
, vol.202
, Issue.1-2
, pp. 145-153
-
-
Leung, P.C.1
Cheng, C.K.2
Zhu, X.M.3
-
62
-
-
4344637399
-
Role of gonadotropin releasing hormone (GnRH) in ovarian cancer
-
Grundker C, Emmons G. Role of gonadotropin releasing hormone (GnRH) in ovarian cancer. Reprod Biol Endocrinol 2003; 1: 65-71
-
(2003)
Reprod Biol Endocrinol
, vol.1
, pp. 65-71
-
-
Grundker, C.1
Emmons, G.2
-
63
-
-
0033786639
-
Oocyte apoptosis is suppressed by disruption of acid sphingomylenase gene or by sphingosin-1-phosoharte therapy
-
Morita Y, Perez GI, Paris F, et al. Oocyte apoptosis is suppressed by disruption of acid sphingomylenase gene or by sphingosin-1-phosoharte therapy. Nat Med 2000; 6: 1109-14
-
(2000)
Nat Med
, vol.6
, pp. 1109-1114
-
-
Morita, Y.1
Perez, G.I.2
Paris, F.3
-
64
-
-
0033851091
-
Side effects of GnRH analogue treatment in childhood
-
Tonini G, Lazzerini M. Side effects of GnRH analogue treatment in childhood. J Pediatr Endocrinol Metab 2000; 13 Suppl. 1: 795-803
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, Issue.1 SUPPL.
, pp. 795-803
-
-
Tonini, G.1
Lazzerini, M.2
-
65
-
-
0036093278
-
Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height
-
Lazar L, Kauli R, Pertzelan A, et al. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab 2002; 87: 2090-4
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 2090-2094
-
-
Lazar, L.1
Kauli, R.2
Pertzelan, A.3
-
66
-
-
0033305638
-
Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty
-
Palmert MR, Mansfiled MJ, Crowley Jr WF, et al. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 1999; 84: 4480-8
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4480-4488
-
-
Palmert, M.R.1
Mansfiled, M.J.2
Crowley Jr., W.F.3
-
67
-
-
2342558594
-
Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty
-
Arrigo T, DeLuca F, Antoniazzi F, et al. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur J Endocrinol 2004; 150: 533-7
-
(2004)
Eur J Endocrinol
, vol.150
, pp. 533-537
-
-
Arrigo, T.1
DeLuca, F.2
Antoniazzi, F.3
-
68
-
-
0028848510
-
Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment
-
Antoniazzi F, Bertoldo F, Zamboni G, et al. Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment. Eur J Endocrinol 1995; 133: 412-7
-
(1995)
Eur J Endocrinol
, vol.133
, pp. 412-417
-
-
Antoniazzi, F.1
Bertoldo, F.2
Zamboni, G.3
-
69
-
-
0027321619
-
Reduction of bone density: An effect of gonadotropin releasing hormone analogue treatment in central precocious puberty
-
Saggese G, Bertelloni F, Zamboni G, et al. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 1993; 152: 717-20
-
(1993)
Eur J Pediatr
, vol.152
, pp. 717-720
-
-
Saggese, G.1
Bertelloni, F.2
Zamboni, G.3
-
71
-
-
0037338882
-
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation
-
Antoniazzi F, Zamboni G, Bertoldo F, et al. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. J Clin Endocrinol Metab 2003; 88: 1096-101
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 1096-1101
-
-
Antoniazzi, F.1
Zamboni, G.2
Bertoldo, F.3
-
72
-
-
0036146298
-
Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients
-
Mericq V, Gajardo H, Eggers M, et al. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients. J Clin Endocrinol Metab 2002; 87: 84-9
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 84-89
-
-
Mericq, V.1
Gajardo, H.2
Eggers, M.3
-
73
-
-
33749370761
-
Efficacy of GnRH analogue (GnRHa) therapy among males with central precocious puberty: Outcome studies
-
[abstract no. A70] Feb 10-13; Salzburg
-
Houk CP, Lee PA. Efficacy of GnRH analogue (GnRHa) therapy among males with central precocious puberty: outcome studies [abstract no. A70]. 8th International Symposium on GnRH analogues; 2005 Feb 10-13; Salzburg
-
(2005)
8th International Symposium on GnRH Analogues
-
-
Houk, C.P.1
Lee, P.A.2
|